The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
Publication
, Journal Article
D'Alessio, DA; Kahn, SE
Published in: Diabetes
January 1, 2025
Duke Scholars
Published In
Diabetes
DOI
EISSN
1939-327X
Publication Date
January 1, 2025
Volume
74
Issue
1
Start / End Page
1 / 3
Location
United States
Related Subject Headings
- Endocrinology & Metabolism
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
D’Alessio, D. A., & Kahn, S. E. (2025). The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research. Diabetes, 74(1), 1–3. https://doi.org/10.2337/dbi24-0046
D’Alessio, David A., and Steven E. Kahn. “The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.” Diabetes 74, no. 1 (January 1, 2025): 1–3. https://doi.org/10.2337/dbi24-0046.
D’Alessio DA, Kahn SE. The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research. Diabetes. 2025 Jan 1;74(1):1–3.
D’Alessio, David A., and Steven E. Kahn. “The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.” Diabetes, vol. 74, no. 1, Jan. 2025, pp. 1–3. Pubmed, doi:10.2337/dbi24-0046.
D’Alessio DA, Kahn SE. The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research. Diabetes. 2025 Jan 1;74(1):1–3.
Published In
Diabetes
DOI
EISSN
1939-327X
Publication Date
January 1, 2025
Volume
74
Issue
1
Start / End Page
1 / 3
Location
United States
Related Subject Headings
- Endocrinology & Metabolism
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences